Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.16 -0.22 (-1.03%)
As of: Nov 16, 2026 · 2:57 PM EST

Amneal Pharmaceuticals (AMRX) EBITDA Margin (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) recorded EBITDA Margin of 17.72% in Q3 2026, up 2.06 percentage points from 15.66% a year earlier but down 5.09 percentage points from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) EBITDA Margin (2017 - 2026) Analysis & Trends

On a TTM basis, Amneal Pharmaceuticals' EBITDA Margin came in at 21.54% as of Sep 30, 2026, up 0.27 percentage points year-over-year; for FY2025, it was 21.20%, up 2.79 percentage points from FY2024.

  • Annual EBITDA Margin has a five-year change of +4.38 percentage points (FY2020 to FY2025).
  • Across earlier years, EBITDA Margin came in at 18.42% in FY2024 (-0.19 pp), 18.60% in FY2023 (+11.65 pp), 6.95% in FY2022 (-11.93 pp) and 18.88% in FY2021 (+2.06 pp).
  • Quarterly EBITDA Margin has ranged from -24.44% in Q2 2022 to 26.14% in Q1 2026 over the past five years.
  • On a year-over-year basis, EBITDA Margin rose in five of the last eight quarters, with an average year-over-year change of +2.72 percentage points.
  • Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 47.76 percentage points in Q2 2023, against a drop of 47.97 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at 22.81% (Q2 2026), 26.14% (Q1 2026) and 20.26% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,280.46 Bn 1,254.07 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 680.99 Bn 600.85 Bn 17.30 Bn 32.68%
3 AbbVie 520.79 Bn 488.80 Bn 13.12 Bn 46.88%
4 Merck 359.41 Bn 322.36 Bn 13.19 Bn 40.60%
5 Novartis Ag 311.49 Bn 284.72 Bn - -
6 Astrazeneca 285.25 Bn 258.90 Bn 13.26 Bn 39.77%
7 Amgen 250.88 Bn 202.54 Bn 7.58 Bn 46.62%
8 Gilead Sciences 208.22 Bn 183.33 Bn 6.73 Bn 50.63%
9 Pfizer 164.67 Bn 112.03 Bn 12.56 Bn 42.49%
10 Amneal Pharmaceuticals 7.10 Bn 6.34 Bn 334.12 Mn 17.72%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 17.72%
Jun 30, 2026 22.81%
Mar 31, 2026 26.14%
Dec 31, 2025 20.26%
Sep 30, 2025 15.66%
Jun 30, 2025 25.35%
Mar 31, 2025 24.30%
Dec 31, 2024 20.36%
Sep 30, 2024 22.46%
Jun 30, 2024 22.58%
Mar 31, 2024 7.83%
Dec 31, 2023 12.28%
Sep 30, 2023 23.02%
Jun 30, 2023 23.31%
Mar 31, 2023 16.98%
Dec 31, 2022 16.27%
Sep 30, 2022 14.03%
Jun 30, 2022 -24.44%
Mar 31, 2022 16.74%
Dec 31, 2021 13.91%
API Access

Amneal Pharmaceuticals EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AMRX&period=max&api_key=YOUR_API_KEY